Brief: Yichang Hec Changjiang Pharmaceutical Sees Turnover Of RMB3.2 Billion For Six Months
July 26 (Reuters) - YiChang HEC ChangJiang
Pharmaceutical 1558.HK :
* SEES TURNOVER OF APPROXIMATELY RMB3.2 BILLION FOR SIX
MONTHS
* SEES NET PROFIT ATTRIBUTABLE OF RMB1 BILLION TO RMB1.2
BILLION
FOR HY
* EXPECTED RESULTS DUE TO OVERALL LIFTING OF DOMESTIC
EPIDEMIC
PREVENTION AND CONTROL POLICIES, AMONG OTHERS
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million